Presented ByProf. MeiLan Han, University of Michigan, MI, USA
TrialPhase 3, RETHINC ConferenceERS 2022
TypePeer-reviewed article
30 October 2022 20:46
Presented ByProf. Leonardo Fabbri, University of Modena and Reggio Emilia, Italy; Dr Konstantinos Kostikas, Novartis Pharma, Switzerland
TrialPhase 3, IMPACT ConferenceERS 2018
TypePeer-reviewed article
7 November 2018 23:05
Presented ByDr Ioannis Psallidas, University of Oxford, United Kingdom; Dr James Donohue, University of North Carolina at Chapel Hill, USA
ConferenceERS 2018
TypePeer-reviewed article
7 November 2018 21:17